The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis
- PMID: 2736799
- PMCID: PMC1541733
The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis
Abstract
Monoclonal antibodies that identify phenotypically distinct macrophage subsets were used to analyse the macrophages in lung biopsy specimens and bronchoalveolar lavage fluid from patients with cryptogenic fibrosing alveolitis. Among the antibodies were RFD1, an interdigitating cell marker, RFD7, a marker for mature tissue macrophages, and RFD9, which identifies epithelioid cells as well as germinal centre macrophages. The lavage fluid was found to contain abnormally high numbers of cells staining with each of the antibodies, a finding that could be explained, at least in part, by an increased frequency of cells expressing more than one marker. In lung tissue macrophage phenotypes within the interstitium were found to differ significantly from those in the alveolar space. Most strikingly, cells bearing the antigen recognized by RFD9 were entirely absent from the interstitial macrophage population, whereas the vast majority in the alveolar lumen were RFD9-positive. The discrete compartmentalization of phenotypically different macrophages within the lung suggests that macrophages may contribute differently to lung pathology in each microenvironment. The functional capacity of the unusual RFD9-positive alveolar macrophages remains to be determined, but their close association with the process of alveolar occlusion indicates a role in the fibrotic process.
Similar articles
-
Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis.Clin Exp Immunol. 1997 Apr;108(1):95-104. doi: 10.1046/j.1365-2249.1997.d01-986.x. Clin Exp Immunol. 1997. PMID: 9097917 Free PMC article.
-
Phenotypic analysis of alveolar macrophages in normal subjects and in patients with interstitial lung disease.Thorax. 1986 Jun;41(6):429-34. doi: 10.1136/thx.41.6.429. Thorax. 1986. PMID: 3787519 Free PMC article.
-
Alveolar macrophage lysosomal enzyme and C3b receptors in cryptogenic fibrosing alveolitis.Clin Exp Immunol. 1980 Apr;40(1):60-5. Clin Exp Immunol. 1980. PMID: 7389217 Free PMC article.
-
Evaluation of alveolitis by studies of lung biopsies.Lung. 1990;168 Suppl:984-92. doi: 10.1007/BF02718236. Lung. 1990. PMID: 2117219 Review.
-
Subclinical alveolitis in immunologic systemic disorders.Lung. 1990;168 Suppl:974-83. doi: 10.1007/BF02718235. Lung. 1990. PMID: 2117218 Review.
Cited by
-
Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease.Clin Exp Immunol. 1991 Sep;85(3):504-9. doi: 10.1111/j.1365-2249.1991.tb05757.x. Clin Exp Immunol. 1991. PMID: 1893632 Free PMC article.
-
Changes to alveolar macrophage phenotype in HIV infected individuals with normal CD4 counts and no respiratory disease.Thorax. 1995 Jul;50(7):777-81. doi: 10.1136/thx.50.7.777. Thorax. 1995. PMID: 7570415 Free PMC article.
-
Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung.Environ Health Perspect. 1992 Jul;97:17-46. doi: 10.1289/ehp.929717. Environ Health Perspect. 1992. PMID: 1396454 Free PMC article. Review.
-
Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.Lung. 1993;171(5):293-303. doi: 10.1007/BF03215872. Lung. 1993. PMID: 7692188
-
Antiretroviral treatment reverses HIV-induced reduction in the expression of surface antigens on alveolar macrophages in AIDS patients.Clin Exp Immunol. 1993 Jan;91(1):13-7. doi: 10.1111/j.1365-2249.1993.tb03346.x. Clin Exp Immunol. 1993. PMID: 8419072 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical